Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenqi Jiangtang
- Development stage
- Unknown
- Lead developer
- People's Hospital of Wuhan University
- Administration
- Oral
01
Overview
Shenqi Jiangtang is a Traditional Chinese Medicine (TCM) formula primarily used for the treatment of type 2 diabetes mellitus (T2DM). It is typically formulated as tablets or granules and is indicated for patients presenting with "Qi and Yin deficiency" syndrome, characterized by symptoms such as thirst, fatigue, and polyuria. The formula contains several herbal components, including *Panax ginseng* (Ginseng), *Astragalus membranaceus* (Astragalus), and *Rehmannia glutinosa*. Its mechanism of action involves improving insulin sensitivity, promoting insulin secretion, and protecting pancreatic islet cells. It is often used as an adjunctive therapy alongside standard oral hypoglycemic agents like metformin to enhance glycemic control and reduce diabetic complications.
- Brand names
- Shenqi Jiangtang TabletsShenqi Jiangtang Granules
- Other names
- Shenqi Jiangtang PianShenqi Jiangtang Keli
02
Targets
INSR (Insulin receptor)VEGFA (Vascular endothelial growth factor A)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)CASP3 (Caspase-3)
Beyond the preview
Go deeper on Shenqi Jiangtang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shenqi Jiangtang.